Streetbeat News

Stock Prices

AHI

Advanced Health Intelligence (AHI) shares were halted on a circuit breaker to the upside, with the stock now up 380.6%.

Portfolio Pulse from Happy Mohamed

June 09, 2023 | 3:15 pm

EXPI

EXp World Holdings shares are trading higher after DA Davidson reiterated a Buy rating on the stock and raised its price target from $14.5 to $20.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 3:11 pm

KC

Kingsoft Cloud Holdings shares are trading higher after CEO Zou Tao purchased 2 million shares for HK$2.625 per share.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 3:11 pm

BLNK

GM

TSLA

Blink Charging shares are trading lower after General Motors announced a partnership with Tesla to use its charging network.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 3:04 pm

FXCOF

RIDE

Lordstown Motors plans to take legal action against Foxconn after the latter failed to close the purchase of approximately 10% of Lordstown's shares for $47.3 million. Lordstown had earlier warned of potential bankruptcy due to uncertainty of a $170 million investment deal with Foxconn.

Portfolio Pulse from Shivani Kumaresan

June 09, 2023 | 3:04 pm

REVG

Four analysts have provided ratings for REV Group (NYSE:REVG) within the last quarter, with an average price target of $13.12, implying a downside compared to the current price of $13.19. The average price target has increased by 10.44% over the past month.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 3:03 pm

LSTR

Over the past 3 months, 6 analysts have published their opinions on Landstar System (NASDAQ:LSTR) stock, with an average 12-month price target of $172.33. The current average has increased by 5.08% from the previous average price target of $164.00.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 3:03 pm

AHI

Advanced Health Intelligence (AHI) shares have resumed trading after a temporary halt.

Portfolio Pulse from Happy Mohamed

June 09, 2023 | 3:02 pm

CRSP

In the last 3 months, 17 analysts have offered 12-month price targets for CRISPR Therapeutics (NASDAQ:CRSP), with an average price target of $66.29, up 12.99% from the previous average of $58.67. The ratings include 5 bullish, 4 somewhat bullish, 7 indifferent, and 1 somewhat bearish.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 3:02 pm

RPTX

Repare Therapeutics (NASDAQ:RPTX) has received 4 bullish analyst ratings in the last quarter, with an average 12-month price target of $23.0, up 27.78% from the previous average of $18.00.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 3:01 pm